Business in Brief: Mylan feels the pain as Teva gets Celebrex booster
Mutual fund assets pass $57.6 billion mark, Sunflower enjoys a Finn romance, and Strauss has a tasty day on TASE.
U.S. clears Teva, Mylan for generic versions of painkiller Celebrex
register with haaretz
Like us on Facebook and get articles directly in your news feed